A randomized, double-blind, Phase 2 study to evaluate subjective and objective outcomes in patients with acute bacterial skin and skin structure infections treated with delafloxacin, linezolid or vancomycin

OBJECTIVES: Delafloxacin is an investigational anionic fluoroquinolone being developed to treat infections caused by Gram-positive and -negative organisms. This clinical trial evaluated the efficacy and safety of delafloxacin in the treatment of acute bacterial skin and skin structure infections (AB...

Descripción completa

Detalles Bibliográficos
Autores principales: Kingsley, Jeff, Mehra, Purvi, Lawrence, Laura E., Henry, Eugenia, Duffy, Erin, Cammarata, Sue K., Pullman, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4743703/
https://www.ncbi.nlm.nih.gov/pubmed/26679243
http://dx.doi.org/10.1093/jac/dkv411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4743703/
https://www.ncbi.nlm.nih.gov/pubmed/26679243
http://dx.doi.org/10.1093/jac/dkv411

Ejemplares similares